Evidence map›Paper›PMID 35811835›Full record

ReviewJournal of market access & health policy2022

Systematic literature review on the implicit factors influencing the HTA deliberative process in Europe.

Clara Monleón, Hans-Martin Späth, Carlos Crespo, Claude Dussart, Mondher Toumi

Abstract readReview
In one paragraph

Review in Journal of market access & health policy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Clara MonleónEA 4129 (Parcours Santé Systémique) Département de Santé Publique, Claude Bernard University, University of Lyon, Lyon, France.ORCID https://orcid.org/0000-0002-7764-6112
Hans-Martin SpäthEA 4129 (Parcours Santé Systémique) Département de Santé Publique, Claude Bernard University, University of Lyon, Lyon, France.ORCID https://orcid.org/0000-0001-8534-4555
Carlos CrespoStatistics Department, University of Barcelona, Barcelona Spain.ORCID https://orcid.org/0000-0001-6066-0818
Claude DussartEA 4129 (Parcours Santé Systémique) Département de Santé Publique, Claude Bernard University, University of Lyon, Lyon, France.ORCID https://orcid.org/0000-0002-1091-9139
Mondher ToumiPublic Health Department, Aix Marseille University, France.ORCID https://orcid.org/0000-0001-7939-7204

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Deliberative processes in Health Technologies Assessment (HTA) result in recommendations that determine the reimbursement of medicines, diagnostics or devices. These processes are governed by explicit criteria, but are also influenced by implicit factors. The objective of this work was to identify the implicit factors influencing HTA deliberative processes in five European countries (France, Germany, Italy, Spain and the UK). Methods: A systematic review of literature published between 2009 and 2019 was conducted. The search was performed in Pubmed, The Cochrane Database of Systematic Reviews, Google Scholar and Center for Reviews and Dissemination. The ISPOR database was searched manually. Results: Out of 100 eligible publications, eight articles were selected for data extraction and analysis. The implicit factors in the HTA deliberative process most frequently mentioned in the identified literature are value judgments, biases, preferences and subjectivity. Five out of the eight articles highlight the need to further improve the transparency of the process, and three provide recommendations on how to address the influence of implicit factors on the HTA deliberative process through a framework. Conclusion: Even in countries with a long HTA history, evidence on implicit factors is scarce. Some methods have been recommended for addressing these factors. Further research is required to characterize the implicit factors in the HTA deliberative process at a country level and explore potential ways to mitigate the influence of these factors on the HTA deliberative process.

Indexed as

decision makingdeliberative processhealthcare systemsHealth technology assessment

Identifiers

PMID35811835
PMCPMC9267410

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.